Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease
- PMID: 23438595
- DOI: 10.1038/ng.2555
Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease
Abstract
Pedigree, linkage and association studies are consistent with heritable variation for complex disease due to the segregation of genetic factors in families and in the population. In contrast, de novo mutations make only minor contributions to heritability estimates for complex traits. Nonetheless, some de novo variants are known to be important in disease etiology. The identification of risk-conferring de novo variants will contribute to the discovery of etiologically relevant genes and pathways and may help in genetic counseling. There is considerable interest in the role of such mutations in complex neuropsychiatric disease, largely driven by new genotyping and sequencing technologies. An important role for large de novo copy number variations has been established. Recently, whole-exome sequencing has been used to extend the investigation of de novo variation to point mutations in protein-coding regions. Here, we consider several challenges for the interpretation of such mutations in the context of their role in neuropsychiatric disease.
Similar articles
-
A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.J Vis Exp. 2011 Jun 15;(52):2534. doi: 10.3791/2534. J Vis Exp. 2011. PMID: 21712793 Free PMC article.
-
De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.Neuron. 2016 Mar 2;89(5):940-7. doi: 10.1016/j.neuron.2016.02.024. Neuron. 2016. PMID: 26938441 Free PMC article.
-
De novo mutations revealed by whole-exome sequencing are strongly associated with autism.Nature. 2012 Apr 4;485(7397):237-41. doi: 10.1038/nature10945. Nature. 2012. PMID: 22495306 Free PMC article.
-
From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease.J Med Genet. 2013 Apr;50(4):203-11. doi: 10.1136/jmedgenet-2013-101519. Epub 2013 Feb 9. J Med Genet. 2013. PMID: 23396985 Review.
-
De novo mutations in human genetic disease.Nat Rev Genet. 2012 Jul 18;13(8):565-75. doi: 10.1038/nrg3241. Nat Rev Genet. 2012. PMID: 22805709 Review.
Cited by
-
Advancing the understanding of autism disease mechanisms through genetics.Nat Med. 2016 Apr;22(4):345-61. doi: 10.1038/nm.4071. Nat Med. 2016. PMID: 27050589 Free PMC article. Review.
-
Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons.FASEB J. 2019 Apr;33(4):5287-5299. doi: 10.1096/fj.201801110RR. Epub 2019 Jan 30. FASEB J. 2019. PMID: 30698461 Free PMC article.
-
Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism.Cell. 2013 Nov 21;155(5):1008-21. doi: 10.1016/j.cell.2013.10.031. Cell. 2013. PMID: 24267887 Free PMC article.
-
A de novo convergence of autism genetics and molecular neuroscience.Trends Neurosci. 2014 Feb;37(2):95-105. doi: 10.1016/j.tins.2013.11.005. Epub 2013 Dec 30. Trends Neurosci. 2014. PMID: 24387789 Free PMC article. Review.
-
De novo Mutations From Whole Exome Sequencing in Neurodevelopmental and Psychiatric Disorders: From Discovery to Application.Front Genet. 2019 Apr 3;10:258. doi: 10.3389/fgene.2019.00258. eCollection 2019. Front Genet. 2019. PMID: 31001316 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
